Literature DB >> 11290546

Molecular determinants of ovarian cancer plasticity.

A K Sood1, E A Seftor, M S Fletcher, L M Gardner, P M Heidger, R E Buller, R E Seftor, M J Hendrix.   

Abstract

During development, the formation and remodeling of primary vascular networks occurs by vasculogenesis and angiogenesis. Recently, the term "vasculogenic mimicry" has been used by our laboratory and collaborators to reflect the embryonic-like ability of aggressive, but not nonaggressive, melanoma tumor cells to form a pattern of matrix-rich networks (containing channels) surrounding spheroids of tumor cells in three-dimensional culture, concomitant with their expression of vascular cell markers. Ovarian cancer is usually diagnosed as advanced stage disease in most patients when widespread metastases have already been established within the peritoneal cavity. In this study, we explored whether invasive ovarian carcinoma cells could engage in molecular vasculogenic mimicry reflected by their plasticity, compared with their normal cell counterparts. The data revealed that the invasive ovarian cancer cells, but not normal ovarian surface epithelial cells, formed patterned networks containing solid and hollow matrix channels when grown in three-dimensional cultures containing Matrigel or type I collagen, in the absence of endothelial cells or fibroblasts. Immunohistochemical analysis showed that matrix metalloproteinases (MMP)-1, -2, and -9, and MT1-MMP were discretely localized to these networks, and the formation of the networks was inhibited by treatment with MMP inhibitors. Furthermore, the RNase protection assay revealed the expression of multiple vascular cell-associated markers by the invasive ovarian cancer cells. In patient tumor sections from high-stage, high-grade ovarian cancers, 7 to 10% of channels containing red blood cells were lined by tumor cells. By comparison, all vascular areas in benign tumors and low-stage cancers were endothelial lined. These results may offer new insights and molecular markers for consideration in ovarian cancer diagnosis and treatment strategies based on molecular vascular mimicry by aggressive tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290546      PMCID: PMC1891929          DOI: 10.1016/S0002-9440(10)64079-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 2.  Regulation of angiogenesis via vascular endothelial growth factor receptors.

Authors:  T Veikkola; M Karkkainen; L Claesson-Welsh; K Alitalo
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

Review 3.  Tumor sinuses- vascular channels.

Authors:  J Tímár; J Tóth
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

4.  Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast Cancer Progression Working Party.

Authors: 
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

Review 5.  Drosophila in cancer research. An expanding role.

Authors:  C J Potter; G S Turenchalk; T Xu
Journal:  Trends Genet       Date:  2000-01       Impact factor: 11.639

Review 6.  Tumor angiogenesis: past, present and the near future.

Authors:  R S Kerbel
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

7.  Distant metastases in ovarian cancer: association with p53 mutations.

Authors:  A K Sood; J I Sorosky; M Dolan; B Anderson; R E Buller
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

Review 8.  Vasculogenic mimicry and tumor angiogenesis.

Authors:  R Folberg; M J Hendrix; A J Maniotis
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

9.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

Authors:  A Eberhard; S Kahlert; V Goede; B Hemmerlein; K H Plate; H G Augustin
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

10.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

View more
  111 in total

1.  XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.

Authors:  Takahito Miyake; Sunila Pradeep; Sherry Y Wu; Rajesha Rupaimoole; Behrouz Zand; Yunfei Wen; Kshipra M Gharpure; Archana S Nagaraja; Wei Hu; Min Soon Cho; Heather J Dalton; Rebecca A Previs; Morgan L Taylor; Takeshi Hisamatsu; Yu Kang; Tao Liu; Sharon Shacham; Dilara McCauley; David H Hawke; John E Wiktorowicz; Robert L Coleman; Anil K Sood
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

2.  Involvement of apoptosis in the formation of vasculogenic mimicry in the malignant neoplasms.

Authors:  A A Vartanyan; E V Stepanova; A Yu Baryshnikov; M R Lichinitser
Journal:  Dokl Biol Sci       Date:  2005 May-Jun

3.  Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.

Authors:  Amy Y Lin; Zhuming Ai; Sang-Chul Lee; Peter Bajcsy; Jacob Pe'er; Lu Leach; Andrew J Maniotis; Robert Folberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

4.  Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.

Authors:  Jyotsnabaran Halder; Charles N Landen; Susan K Lutgendorf; Yang Li; Nicholas B Jennings; Dominic Fan; Gina M Nelkin; Rosemarie Schmandt; Michael D Schaller; Anil K Sood
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

5.  Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.

Authors:  Rebecca L Stone; Keith A Baggerly; Guillermo N Armaiz-Pena; Yu Kang; Angela M Sanguino; Duangmani Thanapprapasr; Heather J Dalton; Justin Bottsford-Miller; Behrouz Zand; Rehan Akbani; Lixia Diao; Alpa M Nick; Koen DeGeest; Gabriel Lopez-Berestein; Robert L Coleman; Susan Lutgendorf; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2014-04-23       Impact factor: 4.742

Review 6.  CD133-targeted niche-dependent therapy in cancer: a multipronged approach.

Authors:  Anthony B Mak; Caroline Schnegg; Chiou-Yan Lai; Subrata Ghosh; Moon Hee Yang; Jason Moffat; Mei-Yu Hsu
Journal:  Am J Pathol       Date:  2014-02-28       Impact factor: 4.307

7.  Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma.

Authors:  Man Li; Yanjun Gu; Zhiguang Zhang; Shiwu Zhang; Danfang Zhang; Ali F Saleem; Xiulan Zhao; Baocun Sun
Journal:  Pathol Oncol Res       Date:  2009-12-17       Impact factor: 3.201

8.  ATP11B mediates platinum resistance in ovarian cancer.

Authors:  Myrthala Moreno-Smith; J B Halder; Paul S Meltzer; Tamas A Gonda; Lingegowda S Mangala; Rajesha Rupaimoole; Chunhua Lu; Archana S Nagaraja; Kshipra M Gharpure; Yu Kang; Cristian Rodriguez-Aguayo; Pablo E Vivas-Mejia; Behrouz Zand; Rosemarie Schmandt; Hua Wang; Robert R Langley; Nicholas B Jennings; Cristina Ivan; Jeremy E Coffin; Guillermo N Armaiz; Justin Bottsford-Miller; Sang Bae Kim; Margaret S Halleck; Mary J C Hendrix; William Bornman; Menashe Bar-Eli; Ju-Seog Lee; Zahid H Siddik; Gabriel Lopez-Berestein; Anil K Sood
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

Review 9.  Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Authors:  Mitsuko Furuya; Junji Ishida; Ichiro Aoki; Akiyoshi Fukamizu
Journal:  Vasc Health Risk Manag       Date:  2008

10.  The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues.

Authors:  K Gaballah; R Oakley; A Hills; A Ryan; M Partridge
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.